Literature DB >> 6279749

Dual system of intestinal thiamine transport in humans.

A M Hoyumpa, R Strickland, J J Sheehan, G Yarborough, S Nichols.   

Abstract

The transport of thiamine across the intestine has been characterized in rats but has not been adequately studied in humans. To determine the kinetics of thiamine intestinal transport directly in humans, mucosal tissues were obtained during routine endoscopy from normal-appearing sites at the second portion of the duodenum. With 3H-dextran as the marker of adherent volume, the uptake of 14C-thiamine hydrochloride by the excised mucosa was measured in vitro. By this method thiamine uptake was linear with tissue weight and with incubation time up to 5 min. Results showed that at low thiamine concentrations (0.2 to 2.0 microM), uptake was saturable whereas at high concentrations (5 to 50 microM), uptake was linear with thiamine concentrations. Pyrithiamine, anoxia, N-ethylmaleimide, and replacement of sodium chloride by mannitol reduced the uptake of 0.5 microM thiamine by 42%, 37%, 32% and 35%, respectively (p less than 0.05) but had no effect on the uptake of 20 microM thiamine. These data suggest that, as in the rat, the intestinal transport of thiamine in humans proceeds by a coexistent dual system. At physiologic concentrations, thiamine is transported primarily by an energy-requiring, sodium-dependent active process, whereas at higher pharmacologic concentrations thiamine uptake is predominantly a passive process.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279749

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Evidence for a carrier-mediated mechanism for thiamine transport to human jejunal basolateral membrane vesicles.

Authors:  Pradeep K Dudeja; Sangeeta Tyagi; Ravinder Gill; Hamid M Said
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

2.  Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects.

Authors:  Howard A Smithline; Michael Donnino; David J Greenblatt
Journal:  BMC Clin Pharmacol       Date:  2012-02-04

3.  Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts.

Authors:  A R Stagg; J C Fleming; M A Baker; M Sakamoto; N Cohen; E J Neufeld
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

4.  Thiamine pyrophosphate biosynthesis and transport in the nematode Caenorhabditis elegans.

Authors:  Liesbeth de Jong; Yan Meng; Joseph Dent; Siegfried Hekimi
Journal:  Genetics       Date:  2004-10       Impact factor: 4.562

5.  Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally.

Authors:  C M Tallaksen; A Sande; T Bøhmer; H Bell; J Karlsen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Comparison of the effects of some thiamine analogues upon thiamine transport across the blood-brain barrier of the rat.

Authors:  J Greenwood; O E Pratt
Journal:  J Physiol       Date:  1985-12       Impact factor: 5.182

7.  A novel homozygous SLC19A2 mutation in a Portuguese patient with diabetes mellitus and thiamine-responsive megaloblastic anaemia.

Authors:  Sophia Tahir; Lieve Gj Leijssen; Maha Sherif; Carla Pereira; Anabela Morais; Khalid Hussain
Journal:  Int J Pediatr Endocrinol       Date:  2015-04-15

8.  Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy.

Authors:  Elena Beltramo; Aurora Mazzeo; Tatiana Lopatina; Marina Trento; Massimo Porta
Journal:  Diab Vasc Dis Res       Date:  2019-11-14       Impact factor: 3.291

9.  Linking vitamin B1 with cancer cell metabolism.

Authors:  Jason A Zastre; Rebecca L Sweet; Bradley S Hanberry; Star Ye
Journal:  Cancer Metab       Date:  2013-07-24

10.  Thiamine and diabetes: back to the future?

Authors:  Elena Beltramo; Aurora Mazzeo; Massimo Porta
Journal:  Acta Diabetol       Date:  2021-06-05       Impact factor: 4.280

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.